Folgen
Elisabetta Cacace
Elisabetta Cacace
ETH Zurich
Bestätigte E-Mail-Adresse bei biol.ethz.ch
Titel
Zitiert von
Zitiert von
Jahr
Unravelling the collateral damage of antibiotics on gut bacteria
L Maier, CV Goemans, J Wirbel, M Kuhn, C Eberl, M Pruteanu, P Müller, ...
Nature 599 (7883), 120-124, 2021
2752021
Chemical genetics in drug discovery
E Cacace, G Kritikos, A Typas
Current opinion in systems biology 4, 35-42, 2017
452017
Systematic analysis of drug combinations against Gram-positive bacteria
E Cacace, V Kim, V Varik, M Knopp, M Tietgen, A Brauer-Nikonow, ...
Nature Microbiology, 1-17, 2023
292023
Dissecting the collateral damage of antibiotics on gut microbes
L Maier, CV Goemans, M Pruteanu, J Wirbel, M Kuhn, E Cacace, ...
BioRxiv, 2020.01. 09.893560, 2020
112020
Logical modeling of cell fate specification—Application to T cell commitment
E Cacace, S Collombet, D Thieffry
Current Topics in Developmental Biology 139, 205-238, 2020
112020
Systematic mapping of antibiotic cross-resistance and collateral sensitivity with chemical genetics
N Sakenova, E Cacace, A Orakov, F Huber, V Varik, G Kritikos, J Michiels, ...
Nature Microbiology 10 (1), 202-216, 2025
32025
McQ–An open-source multiplexed SARS-CoV-2 quantification platform
SC Vonesch, D Bredikhin, N Dobrev, L Villacorta, R Kleinendorst, ...
medRxiv, 2020.12. 02.20242628, 2020
32020
Emergence of OXA-48-like producing Citrobacter species, Germany, 2011 to 2022
J Sommer, H Reiter, J Sattler, E Cacace, J Eisfeld, S Gatermann, ...
Eurosurveillance 29 (15), 2300528, 2024
12024
High-throughput profiling of drug interactions in Gram-positive bacteria
E Cacace, V Kim, M Knopp, M Tietgen, A Brauer-Nikonow, K Inecik, ...
bioRxiv, 2022.12. 23.521747, 2022
12022
Mechanics and Chemistry of Respiration in Health: A Synopsis of the Regulation of Breathing
C Passino, E Cacace, D Caratozzolo, F Rossari, LF Saccaro
The Breathless Heart: Apneas in Heart Failure, 11-33, 2017
12017
Uncovering nitroxoline activity spectrum, mode of action and resistance across Gram-negative bacteria
E Cacace, M Tietgen, M Steinhauer, A Mateus, TG Schultze, ...
bioRxiv, 2024.06. 04.597298, 2024
2024
Compounds and pharmaceutical compositions for prevention and/or treatment of dysbiosis and antibacterial antidotes for microbiome-protection
ARG Brochado, A Typas, L Maier, C Goemans, E Cacace
US Patent App. 17/782,654, 2022
2022
Novel combinations of antibiotics and non-antibiotic drugs effective in vivo against Gram-positive bacteria, in particular methicillin-resistant S. aureus (MRSA)
E Cacace, A Typas, S Göttig
EP Patent App. EP22207154.0, 2022
2022
Das System kann den Vorgang jetzt nicht ausführen. Versuchen Sie es später erneut.
Artikel 1–13